Skip to main content

Mail-Order Pharmacy Reduces Racial Disparities in Adherence to BP Meds


OAKLAND, California — Making prescription refills more affordable and easier to obtain may improve adherence to antihypertensive medication, particularly among certain ethnic groups that currently lag behind in terms of compliance, new research shows [1].
"What is new here is that we really did focus on factors we consider to be modifiable through health-system intervention," lead author Dr Alyce S Adams (Kaiser Permanente Division of Research, Oakland, CA) told heart wire . She and her colleagues report their findings in a paper published online December 10, 2012 in the Archives of Internal Medicine.
 
When we looked at race and added in these issues of copay and mail order pharmacy, we found the difference between blacks and whites in particular--but also between Hispanics and whites--narrowed.
 
"We found that health-system factors such as medication copay and the use of mail-order pharmacy were both associated with better adherence for all races and ethnicities," she explains. "And when we looked at race, controlling for clinical factors, and added in these issues of copay and mail-order pharmacy, we found the difference between blacks and whites in particular--but also between Hispanics and whites--narrowed. So it's equally beneficial across [racial] groups, and if we can get people to sign up for it we have a better shot at getting them to comply with their medication.
"What's encouraging is that we've seen so [many] saying these ethnic differences are persistent and we don't know what to do about them, and these are some very specific concrete things that we can look into," she observes.
Nonwhites More Likely to Be Nonpersistent and Nonadherent to Meds
Adams and colleagues used a hypertension registry at Kaiser Permanente Northern California to conduct a retrospective study of 44 167 adults with high blood pressure who were new users of antihypertensive therapy in 2008. Using multivariate logistic regression analysis, they modeled the relationships between race/ethnicity, specific health-system factors, and early nonpersistence (failing to refill the first prescription within 90 days) and nonadherence (<80% days covered during the first 12 months following the start of treatment), respectively, controlling for sociodemographic and clinical risk factors.
 
We've seen so much saying these ethnic differences are persistent and we don't know what to do about them, and these are some very specific concrete things that we can look into.
 
"Everyone had insurance, so the first hurdle of access was taken care of," Adams notes.
More than 30% of patients were nonpersistent early, and one in five was nonadherent to therapy; nonwhites were more likely to exhibit both types of behavior compared with whites. After multivariate adjustment for sociodemographic, clinical, and health-system factors, blacks were 56% more likely than whites to demonstrate early nonpersistence, Asians 40% more likely, and Hispanics 46% more likely. Corresponding figures for nonadherence were 55%, 13% and 46%.
Of note, racial and ethnic differences in nonadherence were appreciably attenuated when medication copayment and mail-order pharmacy were accounted for in the models. "Medication copay mattered for everybody, as did mail-order pharmacy," Adams says.
More Research Needed on How Mail-Order Pharmacy Affects Adherence
She explained, however, that copays differed between individuals, depending on their exact health plans and a number of other variables, but for the most part the actual cost saving was small.
"But it may be due to the combination of reduced copay and convenience, not having to take that extra step of coming into the pharmacy for medication, that might have been the incentive for people to sign up," she noted.
Nevertheless, more research is needed to explore the specific mechanisms by which use of mail-order pharmacy may influence adherence across diverse healthcare settings, she and her colleagues note.
 
Mail-order pharmacy may not be enough if it's not done in the context of having those supports in place to help you with other aspects of self-management.
 
"We are not really sure why some people sign up [for mail-order pharmacy] and some don't," she told heart wire . "Some of the suggestions that have been made include lack of awareness that it exists, concerns about receiving medications in the post--either privacy concerns or concerns that people don’t have a safe place where the post office can leave a package like that. Those are just two possibilities, but we don't really know, and it's something we need to understand."
And she stresses, "mail-order pharmacy is so different depending on the setting. Here we have an engaged team of people focused on hypertension reduction, but it may not work the same for someone who is not connected to an integrated healthcare system. So that is an important distinction to make. Mail-order pharmacy may not be enough if it's not done in the context of having those supports in place to help you with other aspects of self-management."
The authors report that they have no disclosures.
 

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

Obama Renominates Tavenner to Be CMS Chief

President Barack Obama yesterday renominated Marilyn Tavenner, the acting administrator of the Centers for Medicare & Medicaid Services (CMS), to serve in that post without the caveat of "acting" attached to it. If the Senate approves her nomination, Tavenner will be the first confirmed, full-fledged CMS administrator since Mark McClellan, MD, PhD, stepped down from that position in October 2006, during the George W. Bush administration. Dr. McClellan's successors either were acting administrators or, in the case of Donald Berwick, MD, who was Tavenner's immediate predecessor, a recess appointment. As illustrated by Dr. Berwick's  CMS history , Senate confirmation can be tough to get when one party has enough votes to filibuster and otherwise stymie a nomination by an opposing party's president. That was the case when Obama nominated Dr. Berwick, whom Senate Republicans portrayed as an advocate of healthcare rationing, a characterization denied by t...
Post a Comment
Read more

Secondary Prevention: Clinical Approaches to Managing the Higher-Risk Patient with Heart Disease

INCIDENCE/PREVALENCE/BURDENS ASSOCIATED WITH CARDIOVASCULAR DISEASE (CVD) The prevention of an initial and recurrent cardiovascular event and other complications, such as diabetes and kidney failure [also known as end-stage renal disease (ESRD) or chronic kidney disease (CKD) stage 5] is an important goal in patients with a history of CVD. Each year, approximately 185,000 Americans suffer a recurrent stroke, approximately 470,000 will have a recurrent coronary attack, and an estimated 325,000 will suffer a recurrent myocardial infarction. [1]  Secondary prevention strategies offer the opportunity to prevent further complications and improve outcomes by early detection and management of common comorbidities. The burden on public health and the costs associated with chronic illnesses such as CVD, CKD, and diabetes remain high. An estimated 82.6 million American adults (1 in 3) have 1 or more types of CVD. [1]  Heart failure is the fastest-growing clinical cardiac disease ...
Post a Comment
Read more